Patients and families cannot easily navigate this emerging area of oncology.
Personalized cancer vaccines are one of the more promising areas in modern oncology, but the information environment is fragmented and difficult to interpret. Trial listings are technical, media coverage is inconsistent, and the path from “this exists” to “could this apply to me?” is not clear for most families.
That creates a real gap. Even when the underlying research is advancing, the people who need the information most often cannot access it in a usable way.
